JP2013518040A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013518040A5 JP2013518040A5 JP2012549412A JP2012549412A JP2013518040A5 JP 2013518040 A5 JP2013518040 A5 JP 2013518040A5 JP 2012549412 A JP2012549412 A JP 2012549412A JP 2012549412 A JP2012549412 A JP 2012549412A JP 2013518040 A5 JP2013518040 A5 JP 2013518040A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidino
- asthma
- alkyl
- independently
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1001070.0A GB201001070D0 (en) | 2010-01-22 | 2010-01-22 | Theraputic compounds and their use |
| GB1001070.0 | 2010-01-22 | ||
| PCT/GB2011/000079 WO2011089396A2 (en) | 2010-01-22 | 2011-01-21 | Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013518040A JP2013518040A (ja) | 2013-05-20 |
| JP2013518040A5 true JP2013518040A5 (OSRAM) | 2014-03-06 |
| JP5859980B2 JP5859980B2 (ja) | 2016-02-16 |
Family
ID=42045942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012549412A Expired - Fee Related JP5859980B2 (ja) | 2010-01-22 | 2011-01-21 | チリダニグループ１ペプチダーゼアレルゲン阻害物質としてのピルブアミド化合物及びその使用 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8541363B2 (OSRAM) |
| EP (1) | EP2526116B1 (OSRAM) |
| JP (1) | JP5859980B2 (OSRAM) |
| KR (1) | KR101798676B1 (OSRAM) |
| CN (1) | CN102822192B (OSRAM) |
| AU (1) | AU2011208510B2 (OSRAM) |
| BR (1) | BR112012017476B8 (OSRAM) |
| CA (1) | CA2786690C (OSRAM) |
| CY (1) | CY1116824T1 (OSRAM) |
| DK (1) | DK2526116T3 (OSRAM) |
| ES (1) | ES2544732T3 (OSRAM) |
| GB (1) | GB201001070D0 (OSRAM) |
| HR (1) | HRP20150844T1 (OSRAM) |
| HU (1) | HUE025340T2 (OSRAM) |
| IL (1) | IL220665A (OSRAM) |
| ME (1) | ME02218B (OSRAM) |
| MX (1) | MX2012007711A (OSRAM) |
| NZ (1) | NZ601155A (OSRAM) |
| PL (1) | PL2526116T3 (OSRAM) |
| PT (1) | PT2526116E (OSRAM) |
| RS (1) | RS54148B1 (OSRAM) |
| RU (1) | RU2586215C2 (OSRAM) |
| SG (1) | SG182535A1 (OSRAM) |
| SI (1) | SI2526116T1 (OSRAM) |
| SM (1) | SMT201500215B (OSRAM) |
| WO (1) | WO2011089396A2 (OSRAM) |
| ZA (1) | ZA201204764B (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201001070D0 (en) | 2010-01-22 | 2010-03-10 | St George's Hospital Medical School | Theraputic compounds and their use |
| BR112015008160A2 (pt) * | 2012-10-11 | 2017-07-04 | Hoffmann La Roche | inibidores de imunoproteassoma de cetoamida |
| CN103724334A (zh) * | 2013-10-02 | 2014-04-16 | 张惠琳 | 新的抗变态反应的苯并环庚并噻吩类化合物 |
| US10758569B2 (en) | 2014-01-13 | 2020-09-01 | The General Hospital Corporation | Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin |
| WO2015106242A2 (en) * | 2014-01-13 | 2015-07-16 | The General Hospital Corporation | Bisamide compounds as allosteric effectors for reducing the oxygen-binding affinity of hemoglobin |
| GB201908511D0 (en) | 2019-06-13 | 2019-07-31 | Adorx Therapeutics Ltd | Hydroxamate compounds |
| US20240317801A1 (en) * | 2020-12-17 | 2024-09-26 | Disc Medicine, Inc. | Peptidomimetic matriptase 2 inhibitors and uses thereof |
| US20250064789A1 (en) * | 2022-03-01 | 2025-02-27 | Westvac Biopharma Co., Ltd. | Ketoamide derivatives and pharmaceutical uses thereof |
| WO2024028417A1 (en) | 2022-08-03 | 2024-02-08 | Institut National de la Santé et de la Recherche Médicale | New composition for the treatment and/or prevention of vitiligo |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3149159A (en) | 1962-04-16 | 1964-09-15 | Smith Kline French Lab | Substituted 7-aminoalkylbicyclo-[4. 2. 0] octa-1, 3, 5-trienes |
| EP0100673A2 (en) | 1982-08-02 | 1984-02-15 | The Research Foundation Of State University Of New York | A method of enhancing neurofiber regrowth |
| US5066785A (en) * | 1988-11-15 | 1991-11-19 | City Of Hope | Carboxyl terminal peptide and protein sequencing |
| WO1990012805A1 (fr) | 1989-04-15 | 1990-11-01 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Postostatine et son compose connexe, ou leurs sels |
| US6235929B1 (en) * | 1991-12-27 | 2001-05-22 | Georgia Tech Research Corporation | Tripeptide α-ketoamides |
| DE4331135A1 (de) | 1993-09-14 | 1995-03-16 | Bayer Ag | Neue antiviral wirksame valinhaltige Pseudopeptide |
| US5580854A (en) | 1994-03-04 | 1996-12-03 | Mount Sinai School Of Medicine Of The City University Of New York | Substrate-related peptidyl-aldehyde inhibitors of the proteolytic activity of the multicatalytic proteinase complex |
| EP0793673A1 (en) | 1994-11-24 | 1997-09-10 | Takeda Chemical Industries, Ltd. | Alpha-ketoamide derivatives as cathepsin l inhibitor |
| JPH08208462A (ja) * | 1994-11-24 | 1996-08-13 | Takeda Chem Ind Ltd | カテプシンｌ阻害剤 |
| CA2215211A1 (en) | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
| AU716716B2 (en) * | 1995-07-17 | 2000-03-02 | Medivir Uk Ltd | Cysteine protease inhibitors for use in treatment of IgE mediated allergic diseases |
| EP0873519A4 (en) | 1995-12-07 | 2005-04-27 | Scripps Research Inst | HIV PROTEASE INHIBITORS |
| WO1997030075A1 (de) | 1996-02-16 | 1997-08-21 | Bayer Aktiengesellschaft | Antiviral wirksame oxim- und nitronsubstituierte pseudopeptide |
| CA2225325A1 (en) | 1997-12-19 | 1999-06-19 | The University Of British Columbia | Hemiasterlin analogs |
| BRPI9909660B8 (pt) | 1998-03-19 | 2021-05-25 | Vertex Pharma | compostos inibidores de caspases, composição farmacêutica e uso de ditos compostos |
| US7521068B2 (en) | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| US6774212B2 (en) | 1999-12-03 | 2004-08-10 | Bristol-Myers Squibb Pharma Company | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| JP2002030053A (ja) * | 2000-07-13 | 2002-01-29 | Senju Pharmaceut Co Ltd | α−ケトアミド誘導体の製造法 |
| NZ523781A (en) * | 2000-07-21 | 2004-10-29 | Corvas Int Inc | Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| JP2006503069A (ja) * | 2002-09-25 | 2006-01-26 | ジョージア テック リサーチ コーポレイション | 慢性神経疾患におけるケトアミド阻害剤 |
| JP3858080B2 (ja) | 2003-11-12 | 2006-12-13 | 株式会社信州Ｔｌｏ | アレルゲン分解剤、および抗アレルゲン羽毛 |
| CA2617294A1 (en) | 2005-08-03 | 2007-02-08 | Boehringer Ingelheim International Gmbh | Substituted ethane-1,2-diamines for the treatment of alzheimer's disease ii |
| WO2007041775A1 (en) | 2005-10-10 | 2007-04-19 | The University Of Queensland | Cysteine protease inhibitors incorporating azide groups |
| GB201001070D0 (en) | 2010-01-22 | 2010-03-10 | St George's Hospital Medical School | Theraputic compounds and their use |
| GB201011411D0 (en) | 2010-07-06 | 2010-08-18 | St Georges Hosp Medical School | Therapeutic compounds and their use |
-
2010
- 2010-01-22 GB GBGB1001070.0A patent/GB201001070D0/en not_active Ceased
-
2011
- 2011-01-21 ES ES11701854.9T patent/ES2544732T3/es active Active
- 2011-01-21 SG SG2012052197A patent/SG182535A1/en unknown
- 2011-01-21 US US13/521,067 patent/US8541363B2/en not_active Expired - Fee Related
- 2011-01-21 CA CA2786690A patent/CA2786690C/en not_active Expired - Fee Related
- 2011-01-21 CN CN201180014350.8A patent/CN102822192B/zh not_active Expired - Fee Related
- 2011-01-21 ME MEP-2015-115A patent/ME02218B/me unknown
- 2011-01-21 HR HRP20150844TT patent/HRP20150844T1/hr unknown
- 2011-01-21 JP JP2012549412A patent/JP5859980B2/ja not_active Expired - Fee Related
- 2011-01-21 HU HUE11701854A patent/HUE025340T2/en unknown
- 2011-01-21 RS RS20150506A patent/RS54148B1/sr unknown
- 2011-01-21 NZ NZ601155A patent/NZ601155A/xx not_active IP Right Cessation
- 2011-01-21 WO PCT/GB2011/000079 patent/WO2011089396A2/en not_active Ceased
- 2011-01-21 KR KR1020127021405A patent/KR101798676B1/ko not_active Expired - Fee Related
- 2011-01-21 SI SI201130565T patent/SI2526116T1/sl unknown
- 2011-01-21 PL PL11701854T patent/PL2526116T3/pl unknown
- 2011-01-21 EP EP20110701854 patent/EP2526116B1/en active Active
- 2011-01-21 DK DK11701854.9T patent/DK2526116T3/en active
- 2011-01-21 RU RU2012127709/04A patent/RU2586215C2/ru not_active IP Right Cessation
- 2011-01-21 AU AU2011208510A patent/AU2011208510B2/en not_active Ceased
- 2011-01-21 PT PT117018549T patent/PT2526116E/pt unknown
- 2011-01-21 BR BR112012017476A patent/BR112012017476B8/pt not_active IP Right Cessation
- 2011-01-21 MX MX2012007711A patent/MX2012007711A/es active IP Right Grant
-
2012
- 2012-06-26 ZA ZA2012/04764A patent/ZA201204764B/en unknown
- 2012-06-27 IL IL220665A patent/IL220665A/en not_active IP Right Cessation
-
2013
- 2013-03-28 US US13/852,138 patent/US8637453B2/en active Active
-
2015
- 2015-08-10 CY CY20151100695T patent/CY1116824T1/el unknown
- 2015-09-10 SM SM201500215T patent/SMT201500215B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013518040A5 (OSRAM) | ||
| TWI432198B (zh) | 多芳香族鈉通道阻斷劑 | |
| RU2012127709A (ru) | Пирувамидные соединения в качестве ингибиторов аллергена пылевых клещей 1 группы, представляющего собой пептидазу, и их применение | |
| EP1076657B1 (de) | Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung | |
| RU2170730C2 (ru) | Хинолиновые карбоксамиды и фармацевтическая композиция на их основе | |
| JP2009532417A5 (OSRAM) | ||
| JP2013530179A5 (OSRAM) | ||
| JP2012500260A5 (OSRAM) | ||
| JP2012510502A5 (OSRAM) | ||
| KR20060060027A (ko) | 캡핑된 피라지노일구아니딘 나트륨 채널 차단제 | |
| JP2007518738A5 (OSRAM) | ||
| JP2010506847A5 (OSRAM) | ||
| KR20070026287A (ko) | 병원체로부터의 감염 위험성을 감소시키는 방법 | |
| JP2012524111A5 (OSRAM) | ||
| JP2017518959A5 (OSRAM) | ||
| JP2012504141A5 (OSRAM) | ||
| JP2015507636A5 (OSRAM) | ||
| EP1330455B1 (de) | Neue 7-azaindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung | |
| JP2007502804A5 (OSRAM) | ||
| JP2007505931A5 (OSRAM) | ||
| JP2008515852A5 (OSRAM) | ||
| JP2005511699A5 (OSRAM) | ||
| JP2018509438A5 (OSRAM) | ||
| JP2010540593A5 (OSRAM) | ||
| CN108200769B (zh) | 稠合的苯氧基乙酰胺 |